Hain Celestial's fiscal first quarter 2027 report arrives at a critical juncture for the health-and-wellness food company. Over the past year the firm has been reshaping its operations, divesting its North American snacks business and pursuing the $323 million sale of its International segment to ease a substantial debt burden. These steps have helped lift margins, yet they have also reduced overall revenue and redirected investor focus toward the balance sheet. With the credit facility set to mature in December and the International transaction still pending, the quarter's numbers matter less for the reported loss itself and more for what they indicate about the company's capacity to stabilize sales, produce cash, and address its capital structure.
For the fiscal first quarter of 2027, ended September 30, 2026, Hain Celestial posted net sales of $260.3 million, a 29.3% drop from the prior-year quarter and short of the consensus estimate near $283 million. The adjusted net loss widened to $0.07 per share versus the $0.04 per-share loss that analysts had anticipated, though it improved from the $0.08 adjusted loss recorded a year earlier.
Organic net sales decreased 6.7% year over year, driven by an approximate 7-point decline in volume and mix. On the profitability side the picture was more constructive. Adjusted gross margin rose roughly 320 basis points to 22.8%, aided by the exit from the lower-margin snacks business. North America delivered a 33.5% adjusted gross margin and a 15.6% adjusted EBITDA margin. Selling, general and administrative expenses declined 6% to $62 million. Adjusted EBITDA came in near $18 million, down from $19 million in the fourth quarter, while free cash flow was negative $23 million and net debt increased to about $523 million. The company offered no guidance and, for the second straight quarter, did not hold a question-and-answer session. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Investor reaction to the report was negative, driven by disappointment over the revenue and earnings miss together with ongoing concern about the company's financing situation. Shares declined roughly 7% to about $0.14 in the immediate aftermath, highlighting how much the stock is now trading on balance-sheet risk rather than operational gains. The margin improvement was largely overshadowed by the delayed closing of the International sale and the approaching December maturity of the credit facility. Management's more cautious tone—shifting from confidence about refinancing to "evaluating all available paths"—along with the addition of a Nasdaq listing-risk disclosure in the risk factors weighed on sentiment. For now, the market appears to be pricing in continued distress rather than crediting the margin progress.
The most important near-term catalyst remains the resolution of Hain Celestial's capital structure. The $323 million International divestiture to AURELIUS continues to hinge on a credit-agreement amendment, and the credit facility matures in December. How the company refinances, extends, or otherwise handles that maturity will likely shape the stock's path more than any individual operating metric over the coming months.
On the operating front, investors should monitor whether the North American margin gains are sustained. Management has already implemented roughly $8 million of a planned $16 million SG&A savings program and removed the $25 million of stranded costs associated with the snacks sale ahead of schedule. Maintaining the 30%-plus pro forma gross margin target while stabilizing organic sales will be central to the turnaround story.
Top-line stability is another key variable. Organic revenue has now declined for multiple consecutive quarters, with baby & kids, beverages, and meal prep all facing pressure. Watch for indications that volume and mix trends are leveling off, as well as any updates on the Greek Gods yogurt supply disruption and distribution losses that affected the quarter. With no formal guidance provided, investors will be parsing management's remarks closely for clues on fiscal 2027 revenue and cash-flow expectations.
When evaluating situations like this earnings release, I find Tickeron’s AI Screener particularly useful for quickly screening peers and identifying relevant technical or fundamental patterns. It helps surface comparable names and market setups that complement traditional analysis without replacing it. The tool has become a regular part of how I cross-check ideas across sectors.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HAIN moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend. In 35 of 40 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 88%.
The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HAIN as a result. In 70 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAIN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for HAIN entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 62 cases where HAIN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for HAIN just turned positive on November 04, 2026. Looking at past instances where HAIN's MACD turned positive, the stock continued to rise in 28 of 40 cases over the following month. The odds of a continued upward trend are 70%.
Following a +12.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where HAIN advanced for three days, in 160 of 240 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
HAIN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.088) is normal, around the industry mean (6.914). P/E Ratio (-0.044) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (1.223) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.039) is also within normal values, averaging (5.003).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. HAIN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HAIN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of organic snack food and personal care products
Industry FoodMajorDiversified